Neuroimmune diseases, such as multiple sclerosis, myasthenia gravis, and autoimmune encephalitis, are debilitating conditions ...

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...

Complement receptor 1 had the highest predictive accuracy for adverse event outcomes in PBC and was better than traditional liver fibrosis markers, including the Fibrosis-4 index. The complement ...

Two new studies presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Orlando shed light on how hereditary angioedema (HAE)—a rare, potentially ...

Complement activation in patients with AAV who are in remission may be reflective of ongoing renal scarring. Persistent complement activation during disease remission in antineutrophil cytoplasmic ...